ArticleCancer management and research2024

Clinical Outcome of Extended Curettage with Postoperative Denosumab Administration for the Treatment of Campanacci Grade III Giant Cell Tumors of the Extremities.

Shuai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.